Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 76 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1414. Clear
Clear
Q4
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues
View →
Q4
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q4
THE WASHINGTON TAX & PUBLIC POLICY GROUP for MODERNATX, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · $30,000.00 income
Taxation/Internal Revenue Code
View →
Q4
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q4
VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations
View →
Q4
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate
Health Issues
View →
Q4
HOLLAND & KNIGHT LLP for BLACK WOMEN'S HEALTH IMPERATIVE
4th Quarter (Oct 1 - Dec 31) 2025 · Georgia · House · Senate · $20,000.00 income
Health Issues
View →
Q3
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q3
BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Pharmacy
View →
Q3
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
ALKERMES, INC. for ALKERMES, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate
Medicare/Medicaid, Health Issues, Alcohol and Drug Abuse, Tariff (miscellaneous tariff bills)
View →
Q3
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate
Pharmacy, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q3
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate
Health Issues
View →
Q3
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Pharmacy, Trade (domestic/foreign)
View →
Q3
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q3
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations
View →
Q3
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
2A
VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations
View →
2A
NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Budget/Appropriations
View →
Q2
NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Budget/Appropriations
View →
Q2
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q2
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Previous Page 2 of 4 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem